464 related articles for article (PubMed ID: 36996933)
1. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
[TBL] [Abstract][Full Text] [Related]
2. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
Softic S; Cohen DE; Kahn CR
Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
[TBL] [Abstract][Full Text] [Related]
3. Determining the contribution of a high-fructose corn syrup formulation to hepatic glycogen synthesis during ad-libitum feeding in mice.
DiNunzio G; Belew GD; Torres AN; Silva JG; Silva LP; Barosa C; Tavares L; Jones JG
Sci Rep; 2020 Jul; 10(1):12852. PubMed ID: 32733017
[TBL] [Abstract][Full Text] [Related]
4. Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex-specific manner.
Bhat SF; Pinney SE; Kennedy KM; McCourt CR; Mundy MA; Surette MG; Sloboda DM; Simmons RA
J Physiol; 2021 Mar; 599(5):1487-1511. PubMed ID: 33450094
[TBL] [Abstract][Full Text] [Related]
5. High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation.
Mock K; Lateef S; Benedito VA; Tou JC
J Nutr Biochem; 2017 Jan; 39():32-39. PubMed ID: 27768909
[TBL] [Abstract][Full Text] [Related]
6. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
7. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
[TBL] [Abstract][Full Text] [Related]
8. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).
Rivera JC; Espinoza-Derout J; Hasan KM; Molina-Mancio J; Martínez J; Lao CJ; Lee ML; Lee DL; Wilson J; Sinha-Hikim AP; Friedman TC
Front Endocrinol (Lausanne); 2024; 15():1282231. PubMed ID: 38756999
[TBL] [Abstract][Full Text] [Related]
10. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.
Chung M; Ma J; Patel K; Berger S; Lau J; Lichtenstein AH
Am J Clin Nutr; 2014 Sep; 100(3):833-49. PubMed ID: 25099546
[TBL] [Abstract][Full Text] [Related]
11. Impact of perinatal exposure to sucrose or high fructose corn syrup (HFCS-55) on adiposity and hepatic lipid composition in rat offspring.
Toop CR; Muhlhausler BS; O'Dea K; Gentili S
J Physiol; 2017 Jul; 595(13):4379-4398. PubMed ID: 28447343
[TBL] [Abstract][Full Text] [Related]
12. Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review.
Coronati M; Baratta F; Pastori D; Ferro D; Angelico F; Del Ben M
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334784
[TBL] [Abstract][Full Text] [Related]
13. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
[TBL] [Abstract][Full Text] [Related]
14. Differential Effects of Chronic Ingestion of Refined Sugars versus Natural Sweeteners on Insulin Resistance and Hepatic Steatosis in a Rat Model of Diet-Induced Obesity.
Valle M; St-Pierre P; Pilon G; Marette A
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751772
[TBL] [Abstract][Full Text] [Related]
15. Male 11β-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver Disease.
Larner DP; Morgan SA; Gathercole LL; Doig CL; Guest P; Weston C; Hazeldine J; Tomlinson JW; Stewart PM; Lavery GG
Endocrinology; 2016 Sep; 157(9):3493-504. PubMed ID: 27384305
[TBL] [Abstract][Full Text] [Related]
16. Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced metabolic-associated fatty liver disease via upregulation of Nrf2/HO-1 expressions in C57BL/6J mice.
Wayal V; Hsieh CC
Biomed Pharmacother; 2023 Dec; 168():115724. PubMed ID: 37852102
[TBL] [Abstract][Full Text] [Related]
17. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
Ganz M; Csak T; Szabo G
World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
[TBL] [Abstract][Full Text] [Related]
18. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.
Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS
J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544
[TBL] [Abstract][Full Text] [Related]
19. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
20. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
